Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL.

Blood·2026
Same author

Clinicopathologic and Immunohistochemical Features of Enfortumab Vedotin-Induced Cutaneous Toxicity.

International journal of dermatology·2026
Same author

Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Blood·2026
Same author

Human papilloma virus infection and mismatch repair protein expression in sebaceous neoplasms of the genital area.

Histopathology·2025
Same author

RB1 inactivation in cutaneous carcinomas.

Histopathology·2025
Same author

Mycoplasma pneumoniae-Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases.

Journal of cutaneous pathology·2025
Same journal

Blastic Plasmacytoid Dendritic Cell Neoplasm.

Journal of cutaneous pathology·2026
Same journal

Atypical Grover Disease Associated With Merkel Cell Carcinoma: A Novel Paraneoplastic Presentation.

Journal of cutaneous pathology·2026
Same journal

Profile of a Founder: Herbert Zachareus Lund.

Journal of cutaneous pathology·2026
Same journal

The National Resident Match Program Arrives in Dermatopathology: 15 Years of Resilient Advocacy by the American Society of Dermatopathology's Fellowship Training Program Directors' Committee.

Journal of cutaneous pathology·2026
Same journal

Evaluating Large Language Models for Melanocytic Lesion Pathology Report Interpretation.

Journal of cutaneous pathology·2026
Same journal

An Atypical Skin Presentation of Adult-Onset Still's Disease With Histological Description: A Case Report.

Journal of cutaneous pathology·2026
查看所有相关文章

相关实验视频

Updated: Jul 27, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.5K

在皮肤B细胞淋巴瘤中CD30表达.

Olabisi Afolayan-Oloye1, Lili Zhao2, Trilokraj Tejasvi3

  • 1Department of Pathology, Beaumont Hospital, Royal Oak, Michigan, USA.

Journal of cutaneous pathology
|June 8, 2023
PubMed
概括
此摘要是机器生成的。

在一些皮肤B细胞淋巴瘤 (CBCL) 中发现CD30的表达,特别是皮肤毛囊中心淋巴瘤. 这种表达与有利的临床特征相关,表明潜在的治疗价值.

关键词:
在B细胞淋巴瘤.CD3030 是一个CD3030 是一个CD30.通过皮肤,通过皮肤.

更多相关视频

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

12.7K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

相关实验视频

Last Updated: Jul 27, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.5K
Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

12.7K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

科学领域:

  • 皮肤病学 皮肤病学
  • 在瘤学瘤学.
  • 病理学 病理学 病理学

背景情况:

  • 在皮肤B细胞淋巴瘤 (CBCLs) 中,CD30的表达很少被记录.
  • 了解CD30表达模式对于CBCLs的准确诊断和预后至关重要.
  • 这项研究研究了CD30在各种CBCL亚型和反应性淋巴细胞增生 (RLH) 中的研究.

研究的目的:

  • 在CBCL和RLH患者的队列中检查CD30表达.
  • 为了将CD30表达与CBCL的临床病理特征相关联.
  • 评估CD30在CBCL中的诊断和潜在的治疗影响.

主要方法:

  • 分析了82名CBCL患者和10名RLH患者的CD30表达.
  • CBCL亚型包括原发性皮肤毛囊中心淋巴瘤 (PCFCL),全身/节点毛囊淋巴瘤 (SFL),原发性皮肤边缘区域淋巴瘤 (PCMZL/LPD),全身边缘区域淋巴瘤 (SMZL) 和原发性皮肤扩散大B细胞淋巴瘤,腿类型 (PCDLBCL-LT).
  • 表达被评分为强度和程度,并与临床数据相关联,包括年龄,性别,PET/CT发现,LDH水平和骨髓状况.

主要成果:

  • 在35%的CBCL病例中检测到CD30表达,强度和程度各不相同.
  • 在PCFCL中表达最频繁,在PCDLBCL-LT中没有表达.
  • 在CBCL中CD30表达与有利的临床指标相关:年龄较小,阴性PET/CT和正常的LDH水平.

结论:

  • CD30可以在CBCL表达,可能导致诊断挑战.
  • PCFCL最常见的是CD30表达,与有利的预后因素有关.
  • 强烈和扩散的CD30表达可能在特定的CBCL病例中代表治疗点.